MMP14
protein-codingmatrix metallopeptidase 14, the group of M10 matrix metallopeptidases
Gene summary
Proteins of the matrix metalloproteinase (MMP) family are involved in the breakdown of extracellular matrix in normal physiological processes, such as embryonic development, reproduction, and tissue remodeling, as well as in disease processes, such as arthritis and metastasis. Most MMP's are secreted as inactive proproteins which are activated when cleaved by extracellular proteinases. However, the protein encoded by this gene is a member of the membrane-type MMP (MT-MMP) subfamily; each member of this subfamily contains a potential transmembrane domain suggesting that these proteins are expressed at the cell surface rather than secreted. This protein activates MMP2 protein, and this activity may be involved in tumor invasion. [provided by RefSeq, Jul 2008]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~12.5 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0010201
Submitter: G2P
Inheritance Pattern: Unknown
Disease ID:MONDO:0010201
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0018298
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0010201
Submitter: Ambry Genetics
Clinical Genomic Database (CGD)
Manifestation: Biochemical; Craniofacial; Musculoskeletal
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to MMP14 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_004995.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 3 | 80 | 4 | 87 | ||
| missense | 2 | 194 | 5 | 3 | 204 | |
| nonsense | 3 | 3 | ||||
| start loss | 0 | |||||
| frameshift | 1 | 1 | ||||
| splice donor/acceptor (+/-2bp) | 3 | 3 | ||||
| Total | 2 | 0 | 204 | 85 | 7 | 298 |
Highest pathogenic variant AF is 0.000004104287
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_004986.1 | 10 | MANE Select | |
| Ensembl | ENSP00000308208.6 | 10 | MANE Select | |
| Ensembl | ENSP00000450323.1 | 2 | Standard | |
| Ensembl | ENSP00000506068.1 | 10 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| mmp14b | Danio rerio | Structure: auditory capsule Quality: morphology abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- GnRH signaling pathway - Homo sapiens (human)
- TNF signaling pathway - Homo sapiens (human)
- Matrix Metalloproteinases
- Angiogenesis overview
- AGE-RAGE pathway
Biological Process
- skeletal system development
- angiogenesis
- ovarian follicle development
- response to hypoxia
- endothelial cell proliferation
Molecular Function
- endopeptidase activity
- metalloendopeptidase activity
- serine-type endopeptidase activity
- integrin binding
- protein binding
Cellular Component
- extracellular space
- nucleus
- cytoplasm
- Golgi lumen
- cytosol
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000311852
- Coding exons
- 10
- Length
- 12471
- Individuals with no LoFs
- 125458
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 290
- Defined
- 125748
- p
- 0.00115
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.48 | 290 | 370 | 0.783 | 0.0000229 | 3797 |
| Missense (PolyPhen) | 109 | 171.81 | 0.63441 | 1736 | ||
| Synonymous | 0.244 | 152 | 156 | 0.975 | 0.0000107 | 1153 |
| Loss of Function | 4.48 | 3 | 29.1 | 0.103 | 0.00000156 | 299 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.0013 | 0.0012 | notable |
| Latino/Admixed American | 0.00035 | 0.00035 | rare |
| Ashkenazi Jewish | 0.00010 | 0.000099 | rare |
| East Asian | 0.0053 | 0.0053 | notable |
| Finnish | 0.0015 | 0.0014 | notable |
| European (Non-Finnish) | 0.0010 | 0.0010 | notable |
| South Asian | 0.00026 | 0.00026 | rare |
| Other | 0.0012 | 0.0011 | notable |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Endopeptidase that degrades various components of the extracellular matrix such as collagen. Activates progelatinase A. Essential for pericellular collagenolysis and modeling of skeletal and extraskeletal connective tissues during development (By similarity). May be involved in actin cytoskeleton reorganization by cleaving PTK7 (PubMed:20837484). Acts as a positive regulator of cell growth and migration via activation of MMP15. Involved in the formation of the fibrovascular tissues in association with pro-MMP2 (PubMed:12714657). Cleaves ADGRB1 to release vasculostatin-40 which inhibits angiogenesis (PubMed:22330140). {ECO:0000250|UniProtKB:P53690, ECO:0000269|PubMed:12714657, ECO:0000269|PubMed:20837484, ECO:0000269|PubMed:22065321, ECO:0000269|PubMed:22330140}.;
- Disease
- DISEASE: Winchester syndrome (WNCHRS) [MIM:277950]: A disease characterized by severe osteolysis in the hands and feet, generalized osteoporosis, bone thinning, and absence of subcutaneous nodules. Various additional features include coarse face, corneal opacities, gum hypertrophy, and EKG changes. {ECO:0000269|PubMed:22922033}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.557
Intolerance Scores
- LoFtool
- 0.0497
- RVIS EVS
- 0.05
- RVIS percentile EVS
- 57.48
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- S
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.587
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |